Antigen binding proteins that bind CCR2
View Patent ↗There is disclosed compositions and methods relating to or derived from anti-CCR2 antibodies. More specifically, there is disclosed fully human antibodies that bind CCR2, CCR2-binding fragments and derivatives of such antibodies, and CCR2-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing subjects having CCR2 related disorders or conditions.
1. A recombinant fully human antibody of an IgG class that binds to a CC-Chemokine Receptor 2 (CCR2) epitope, wherein the antibody has a heavy chain variable domain sequence that is at least 95% identical to an amino acid sequence selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 25, and SEQ ID NO. 27, and has a light chain variable domain sequence that is at least 95% identical to an amino acid sequence selected from the group consisting of SEQ ID NO. 2, SEQ ID NO. 26, and SEQ ID NO. 28, and wherein the antibody has a heavy chain/light chain variable domain sequence pairing that is at least 95% identical to the amino acid sequences selected from the group consisting of SEQ ID NO. 1/SEQ ID NO. 2 SEQ ID NO. 25/SEQ ID NO. 26, and SEQ ID NO. 27/SEQ ID NO. 28.
2. A Fab fully human antibody fragment that binds to a CCR2 epitope, having a heavy chain variable domain and a light chain variable domain, wherein the antibody fragment has a heavy chain variable domain sequence that is at least 95% identical to an amino acid sequence selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 25, and SEQ ID NO. 27, and has a light chain variable domain sequence that is at least 95% identical to an amino acid sequence selected from the group consisting of SEQ ID NO. 2, SEQ ID NO. 26, and SEQ ID NO. 28, and wherein the antibody has a heavy chain/light chain variable domain sequence pairing that is at least 95% identical to an amino acid sequence pairing selected from the group consisting of SEQ ID NO. 1/SEQ ID NO. 2, SEQ ID NO. 25/SEQ ID NO. 26, and SEQ ID NO. 27/SEQ ID NO. 28.
3. A single chain human antibody that binds to a CCR2 epitope, having a heavy chain variable domain, a light chain variable domain, and a peptide linker connecting the heavy chain and light chain variable domains, wherein the heavy chain variable domain has a sequence that is at least 95% identical to an amino acid sequence selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 25, and SEQ ID NO. 27, and the light chain variable domain has a sequence that is at least 95% identical to an amino acid sequence selected from the group consisting of SEQ ID NO. 2, SEQ ID NO. 26, and SEQ ID NO. 28, and wherein the single chain antibody has a heavy chain/light chain variable domain sequence pairing that is at least 95% identical to an amino acid sequence pairing selected from the group consisting of SEQ ID NO. 1/SEQ ID NO. 2, SEQ ID NO. 25/SEQ ID NO. 26, and SEQ ID NO. 27/SEQ ID NO. 28.
4. An anti-CC-Chemokine Receptor 2 (anti-CCR2) recombinant antibody comprising a heavy chain variable domain having an amino acid sequence selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 25, SEQ ID NO. 27, SEQ ID NO. 29, and SEQ ID NO. 37, and comprising a light chain variable domain having an amino acid sequence selected from the group consisting of SEQ ID NO. 2, SEQ ID NO. 16, SEQ ID NO. 26, SEQ ID NO. 28, and SEQ ID NO. 32, wherein the antibody is an IgG.
5. The anti-CCR2 antibody of claim 4 , wherein the heavy chain variable domain has an amino acid sequence as set forth in SEQ ID NO: 1, and the light chain variable domain has an amino acid sequence as set forth in SEQ ID NO: 2.
6. The anti-CCR2 antibody of claim 4 , wherein the heavy chain variable domain has an amino acid sequence as set forth in SEQ ID NO: 25 and the light chain variable domain has an amino acid sequence as set forth in SEQ ID NO: 26.
7. The anti-CCR2 antibody of claim 4 , wherein the heavy chain variable domain has an amino acid sequence as set forth in SEQ ID NO: 27, and the light chain variable domain has an amino acid sequence as set forth in SEQ ID NO: 28.
8. An anti-CC-Chemokine Receptor 2 (anti-CCR2) recombinant single chain antibody or an anti-CCR2 recombinant Fab fully human antibody fragment, comprising a heavy chain variable domain having an amino acid sequence selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 25, SEQ ID NO. 27, SEQ ID NO. 29, and SEQ ID NO. 37, and comprising a light chain variable domain having an amino acid sequence selected from the group consisting of SEQ ID NO. 2, SEQ ID NO. 16, SEQ ID NO. 26, SEQ ID NO. 28, and SEQ ID NO. 32.